CATAPULT AWARD: CLINICAL TRIAL AWARDS IN PEDIATRIC CANCER 2022

CURESEARCH FOR CHILDREN’S CANCER

Object

Topic: Pediatric cancer.

Destination: Catapult Awards provide funding for Phase 1 or Phase 2 clinical trials that advance promising therapies for pediatric cancer. The Catapult Award uniquely funds cutting-edge clinical trials that begin enrolling patients in less than a year, and every applicant must provide a development plan that demonstrates their ability to move into later-phase clinical trials if successful

Budget: Up to $2,500,000.

Duration: 1-3 years.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: